₹2,800.00
SITACRED-D
Product Composition:
Effective diabetes management requires more than just monitoring; it requires a treatment that addresses the various ways the body processes sugar. SITACRED-D, a premium formulation from Novalab Cardiac, combines two powerful medications—Sitagliptin Phosphate (100mg) and Dapagliflozin (10mg)—to provide a comprehensive solution for adults with Type 2 diabetes mellitus.
SITACRED-D is a fixed-dose combination (FDC) therapy designed for patients whose blood sugar levels are not adequately managed by diet, exercise, or a single medication alone. By bringing together two distinct classes of antidiabetic agents, this tablet simplifies your treatment routine while maximizing glucose control.
The success of SITACRED-D lies in its synergistic approach, targeting blood sugar from two different biological angles:
1. Sitagliptin (The DPP-4 Inhibitor)
Sitagliptin works by increasing the levels of natural substances called incretins in your body. These hormones help regulate blood sugar by:
2. Dapagliflozin (The SGLT2 Inhibitor)
Dapagliflozin focuses on the kidneys. Unlike many other treatments, it works independently of insulin by:
SITACRED-D is primarily used to improve glycemic control in adults with Type 2 diabetes. It is an ideal choice for:
Choosing SITACRED-D offers several positive health advantages beyond simple sugar management:
1. Consistent Blood Sugar Control
The combination of two mechanisms helps maintain stable blood glucose levels throughout the entire day, reducing the risk of sudden spikes and dips.
2. Weight Management Support
Dapagliflozin is known to help the body lose a modest amount of weight because it removes excess calories (in the form of sugar) through the urine. This makes SITACRED-D a “weight-friendly” option compared to some other diabetes treatments that might cause weight gain.
3. Heart and Kidney Protection
Recent clinical evidence suggests that SGLT2 inhibitors like Dapagliflozin may offer long-term protection for the heart and kidneys. It helps reduce the risk of heart-related complications and supports better kidney health in high-risk patients.
4. Low Risk of Hypoglycemia
When used as a standalone therapy (without insulin or certain other medications), the combination in SITACRED-D has a very low risk of causing dangerously low blood sugar (hypoglycemia).
5. Convenient Once-Daily Dosing
Instead of taking multiple separate pills, SITACRED-D combines your therapy into a single, easy-to-swallow tablet. This convenience makes it much easier to stay consistent with your treatment plan.
At Novalab Cardiac, we are dedicated to providing life-saving medications with the highest quality standards. SITACRED-D is manufactured in world-class facilities to ensure that every dose is pure, potent, and effective. By managing your blood sugar effectively today, you are protecting yourself from future complications like nerve damage, vision loss, and heart issues.
SITACRED-D is your partner in achieving a healthier, more balanced life with Type 2 diabetes.
| Packing | 10×10(Alu-Alu) |
|---|
This will close in 0 seconds
Automated page speed optimizations for fast site performance